Immix Biopharma News

Immix Biopharma | 10-K: Annual report

Mar 29 16:09 ET

Immix Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 20 12:46 ET

Immix Biopharma | 424B5: Prospectus

Feb 7 17:17 ET

Immix Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(5.8%),Orin H(5.8%)

Feb 7 09:21 ET

Immix Biopharma | 8-K: Current report

Feb 6 09:12 ET

Immix Biopharma | 424B5: Prospectus

Feb 5 16:46 ET

Immix Biopharma | 8-K: Current report

Feb 5 16:38 ET

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason

Dec 12, 2023 18:25 ET

Immix Biopharma: Q3 2023 Earnings Report

Nov 9, 2023 20:24 ET

Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-CFO Morris Gabriel S

Nov 9, 2023 19:57 ET

Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Rachman Ilya M

Nov 9, 2023 19:54 ET

Immix Biopharma | EFFECT: Others

Sep 29, 2023 00:15 ET

Immix Biopharma | CORRESP: CORRESP

Sep 26, 2023 16:30 ET

Immix Biopharma | UPLOAD: Others

Sep 26, 2023 15:30 ET

Immix Biopharma | S-3: Registration statement for specified transactions by certain issuers

Sep 25, 2023 16:15 ET

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason

Sep 18, 2023 19:03 ET

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Ng Carey

Sep 15, 2023 18:27 ET

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adams Helen C.

Sep 14, 2023 17:20 ET

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason

Sep 12, 2023 16:58 ET

Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BUCHAN MELISSA JANE

Sep 11, 2023 17:18 ET